Fuente: WIPO "tomato" Therapeutic methods and pharmaceutical compositions for treating or preventing mast cell activation syndrome (MCAS), eosinophilic esophagitis (EoE), or a food allergy in a human subject are described. The disclosure also includes therapeutic methods of reducing or alleviating symptoms of MCAS, EoE, or a food allergy in a human subject.